Form 4: Cutera Inc. Executive Jeffrey S. Jones Reports Stock Option Grant
SEC Form 4 Filing
Cutera Inc.'s Chief Operating Officer, Jeffrey S. Jones, reports the acquisition of stock options.
Summary
- On May 13, 2024, Jeffrey S. Jones, Chief Operating Officer of Cutera Inc., reported a transaction involving derivative securities.
- Jones acquired stock options for 45,000 shares of Cutera Inc. at an exercise price of $2.23.
- These options vest monthly over four years starting April 25, 2024, contingent upon continued service with the company.
- The options expire on May 13, 2031, but may expire earlier if Jones' service with the company terminates.
- Following this transaction, Jones directly owns 101,256 derivative securities.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a stock option grant. It's a standard practice, so neither particularly positive nor negative.
Positives
- The grant of stock options to the COO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Risks
- The value of the stock options is dependent on the future performance of Cutera Inc.'s stock.
- The options may expire worthless if the stock price remains below the exercise price of $2.23.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the stock option grant suggests an expectation of future value creation.
Industry Context
Stock option grants are a common form of executive compensation in the technology and medical device industries, aligning management's interests with those of shareholders by incentivizing them to increase the company's stock value.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in the medical device industry.
- Companies like Syneron Candela and Cynosure also utilize stock options to incentivize their executives.
- The vesting schedule of 1/48 per month is a standard vesting arrangement.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it aligns management's interests with increasing shareholder value.
- Employees may see the grant as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| April 25, 2024 | Start date for monthly vesting of stock options. |
| May 13, 2024 | Date of transaction: acquisition of stock options. |
| May 13, 2031 | Expiration date of the stock options, subject to earlier expiration upon termination of service. |
| May 14, 2024 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, Cutera Inc., CUTR, Jeffrey S. Jones, Chief Operating Officer, derivative securities, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.